相关实验视频

Updated: Jul 1, 2025

Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation

Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation

Published on: November 17, 2014

罗酶抑制剂通过调节其STAT3和STAT5激活来缓解CD4⁺T细胞介导的角膜移植排斥

Shang Li¹, Peng Zhang¹, Ao Li¹

¹Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing, China.

Experimental eye research

|March 13, 2024

概括

罗激酶 (ROCK) 抑制剂,如Y27632,可以通过调节免疫细胞来预防角膜移植排斥. 这涉及调节STAT3和STAT5通路,以平衡调节性T细胞 (Tregs) 和T辅助17 (Th17) 细胞.

科学领域:

免疫学免疫学免疫学
眼科医生眼科眼科
药理学药理学是指药理学的学科.

背景情况:

角膜移植对于恢复视力至关重要,但由于免疫排斥而面临移植失败.
罗关联蛋白激酶 (ROCK) 抑制剂通过STATs通路激活与自身免疫性疾病有关.
ROCK 抑制剂可能通过通过 STATs 途径影响 CD4+ T 细胞分化来影响角膜移植免疫力.

研究的目的:

调查ROCK-STATs途径在角膜移植免疫排斥中的作用.
在角膜移植模型中确定ROCK抑制剂Y27632对免疫细胞群和信号通路的影响.

主要方法:

向接受者小鼠和分离的CD4+T细胞注射Y27632,一种ROCK抑制剂.
在脏和淋巴结中分析STAT3和STAT5酸化水平.
流细胞测量以评估CD4+T细胞子集 (Tregs,Th17) 和树突细胞群.
定量PCR测量在移植组织中相关基因 (ROCK1,ROCK2,CD11c,IL-17A,Helios) 的mRNA表达.

主要成果:

在CD4+T细胞中,Y27632增加了STAT5酸化和减少了STAT3酸化.
Y27632促进了CD4+CD25+Foxp3+Helios+Tregs的扩张,并减少了CD4+IL17A+Th17细胞.
Y27632降低了树突细胞比例和CD86表达,但没有影响巨细胞.
移植组织显示ROCK1,ROCK2,CD11c,IL-17AmRNA减少,HeliosmRNA表达增加.

结论:

ROCK 抑制剂通过调节 STAT3 和 STAT5 酸化来调节 Treg/Th17 平衡.
这种调制有效地抑制了异性角膜移植中的免疫排斥.
ROCK-STATs途径为改善角膜移植结果提供了潜在的治疗标.

关键词:

角膜移植角膜移植在国家统计局.Th17 这是一个很好的方法.这就是Treg Treg.Y27632 Y27632 的意思是什么?

更多相关视频

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...